Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FMC Corp (FMC) vs Medtronic PLC (MDT) Price & Performance

Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

FMC Corp vs Medtronic PLC — how do they compare? FMC Corp trades at $8.39 (market cap $1.39B), while Medtronic PLC trades at $87.75 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 80.7× FMC Corp's market cap, and FMC Corp pays the higher dividend (3.59%). Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Medtronic PLC for 63 Days on average.

FMCMDT
Market Cap
$1.39B$112.24B
Volume
4,145,979105,663,236
Sector
Basic MaterialsHealth
52-Week High
$30.63$105.35
52-Week Low
$8.44$73.75
Typical Hold Time
68 Days63 Days
Enterprise Value
$5.19B$131.58B
Dividend Yield
3.59%3.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

FMC Corp

FMC Corporation (NYSE: FMC) trades at $8.695, down 4.35% today, reflecting ongoing challenges in the agricultural chemicals sector. The stock shows bearish technical signals with mixed earnings performance - beating Q1 and Q2 2026 estimates but missing Q4 2025. Fundamentally, the company faces significant headwinds with a net income margin of -84.83% and negative ROE of -91.47%, though valuation metrics like P/S of 0.34 and P/B of 0.85 suggest potential undervaluation. Recent developments include regulatory submissions for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.

The investment outlook remains cautious despite analyst consensus pointing to 68% upside potential with a $14.60 price target. While aggressive deleveraging efforts and new product pipelines offer potential catalysts, substantial earnings losses, volatile cash flows, and high debt levels present significant risks. The agricultural sector's cyclical nature and pricing pressures require careful monitoring of the company's turnaround execution and market conditions.

Medtronic PLC

Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.

MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FMC
0% Buy100% Sell
Avg holding period · 68 Days
MDT
53% Buy47% Sell
Avg holding period · 63 Days

Top news

Latest headlines on both assets

About FMC Corp

FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.

Read more on FMC →

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →